133 related articles for article (PubMed ID: 38299213)
1. Activation of farnesoid X receptor retards expansion of renal collecting duct cell-derived cysts via inhibition of CFTR-mediated Cl
Srimai N; Tonum K; Soodvilai S
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F600-F610. PubMed ID: 38299213
[TBL] [Abstract][Full Text] [Related]
2. Pinostrobin inhibits renal CFTR-mediated Cl
Tonum K; Chabang N; Fongsupa S; Chantawarin S; Jiarpinitnun C; Tuchinda P; Soodvilai S
J Pharmacol Sci; 2022 Apr; 148(4):369-376. PubMed ID: 35300812
[TBL] [Abstract][Full Text] [Related]
3. Activation of liver X receptors reduces CFTR-mediated Cl(-) transport in kidney collecting duct cells.
Raksaseri P; Chatsudthipong V; Muanprasat C; Soodvilai S
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F583-91. PubMed ID: 23720350
[TBL] [Abstract][Full Text] [Related]
4. Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
Pathomthongtaweechai N; Soodvilai S; Chatsudthipong V; Muanprasat C
Eur J Pharmacol; 2014 Feb; 724():67-76. PubMed ID: 24360935
[TBL] [Abstract][Full Text] [Related]
5. Steviol reduces MDCK Cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation.
Yuajit C; Homvisasevongsa S; Chatsudthipong L; Soodvilai S; Muanprasat C; Chatsudthipong V
PLoS One; 2013; 8(3):e58871. PubMed ID: 23536832
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Stanton BA
Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
[TBL] [Abstract][Full Text] [Related]
7. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
[TBL] [Abstract][Full Text] [Related]
8. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
Li H; Findlay IA; Sheppard DN
Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
[TBL] [Abstract][Full Text] [Related]
9. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
[TBL] [Abstract][Full Text] [Related]
10. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
Tonum K; Srimai N; Chabang N; Fongsupa S; Tuchinda P; Torres JA; Weimbs T; Soodvilai S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457146
[TBL] [Abstract][Full Text] [Related]
12. Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth.
Li H; Yang W; Mendes F; Amaral MD; Sheppard DN
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1176-86. PubMed ID: 22874761
[TBL] [Abstract][Full Text] [Related]
13. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
[TBL] [Abstract][Full Text] [Related]
14. Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion.
Nantavishit J; Chatsudthipong V; Soodvilai S
Biochem Pharmacol; 2018 Aug; 154():175-182. PubMed ID: 29746821
[TBL] [Abstract][Full Text] [Related]
15. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 22186622
[TBL] [Abstract][Full Text] [Related]
16. Epithelial transport in polycystic kidney disease.
Sullivan LP; Wallace DP; Grantham JJ
Physiol Rev; 1998 Oct; 78(4):1165-91. PubMed ID: 9790573
[TBL] [Abstract][Full Text] [Related]
17. The cystic fibrosis transmembrane regulator (CFTR) in the kidney.
Morales MM; Falkenstein D; Lopes AG
An Acad Bras Cienc; 2000 Sep; 72(3):399-406. PubMed ID: 11028104
[TBL] [Abstract][Full Text] [Related]
18. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.
Magenheimer BS; St John PL; Isom KS; Abrahamson DR; De Lisle RC; Wallace DP; Maser RL; Grantham JJ; Calvet JP
J Am Soc Nephrol; 2006 Dec; 17(12):3424-37. PubMed ID: 17108316
[TBL] [Abstract][Full Text] [Related]
19. TMEM16A drives renal cyst growth by augmenting Ca
Cabrita I; Buchholz B; Schreiber R; Kunzelmann K
J Mol Med (Berl); 2020 May; 98(5):659-671. PubMed ID: 32185407
[TBL] [Abstract][Full Text] [Related]
20. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
